Latest Regulatory Clearance News

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.

Arafura Rare Earths has locked in binding cornerstone equity agreements worth approximately A$230 million with German and Australian government-backed funds, advancing the financing of its Nolans Rare Earths Project.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

Boab Metals has received the crucial regulatory green light for its Sorby Hills project, clearing the way for full-scale mining operations and first concentrate production targeted in late 2027.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

Iceni Gold Limited has successfully raised $1.55 million to advance exploration at its flagship 14 Mile Well project and has acquired a significant tenement package near the Granny Smith mine, positioning itself for growth in Western Australia's premier gold district.

Neometals Ltd has released a positive scoping study for its Ironclad gold deposit at the Barrambie Gold Project, outlining a rapid production pathway with potential output of up to 11,000 ounces of gold within a year.

Arovella Therapeutics has secured TGA confirmation to advance its Phase 1 trial of ALA-101 in Australia via the efficient Clinical Trial Notification pathway, following FDA clearance in the US.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Pan African Resources has agreed to acquire Emmerson Resources via a scheme of arrangement valued at approximately A$311 million, offering Emmerson shareholders a 36.4% premium. The deal aligns interests in the Tennant Creek Joint Venture and provides exposure to a larger gold producer.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.